122 related articles for article (PubMed ID: 38292306)
1. Understanding YTHDF2-mediated mRNA Degradation By m
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
ArXiv; 2024 Jan; ():. PubMed ID: 38292306
[TBL] [Abstract][Full Text] [Related]
2. Understanding YTHDF2-mediated mRNA degradation by m6A-BERT-Deg.
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622358
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
4. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
5. Ythdf2-mediated m
Li M; Zhao X; Wang W; Shi H; Pan Q; Lu Z; Perez SP; Suganthan R; He C; Bjørås M; Klungland A
Genome Biol; 2018 May; 19(1):69. PubMed ID: 29855337
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine-dependent regulation of messenger RNA stability.
Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
[TBL] [Abstract][Full Text] [Related]
7. UPF1 promotes rapid degradation of m
Boo SH; Ha H; Lee Y; Shin MK; Lee S; Kim YK
Cell Rep; 2022 May; 39(8):110861. PubMed ID: 35613594
[TBL] [Abstract][Full Text] [Related]
8. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21
Liu R; Miao J; Jia Y; Kong G; Hong F; Li F; Zhai M; Zhang R; Liu J; Xu X; Wang T; Liu H; Hu J; Yang Y; He A
Oncogene; 2023 May; 42(20):1607-1619. PubMed ID: 37012388
[TBL] [Abstract][Full Text] [Related]
11. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
12. YTHDF2 Regulates Maternal Transcriptome Degradation and Embryo Development in Goat.
Deng M; Chen B; Liu Z; Cai Y; Wan Y; Zhang G; Fan Y; Zhang Y; Wang F
Front Cell Dev Biol; 2020; 8():580367. PubMed ID: 33117808
[TBL] [Abstract][Full Text] [Related]
13. Ythdf2-mediated STK11 mRNA decay supports myogenesis by inhibiting the AMPK/mTOR pathway.
Deng K; Liu Z; Li X; Ren C; Fan Y; Guo J; Li P; Deng M; Xue G; Yu X; Shi J; Zhang Y; Wang F
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127614. PubMed ID: 37884231
[TBL] [Abstract][Full Text] [Related]
14. m
Boo SH; Ha H; Kim YK
Cell Rep; 2022 Sep; 40(10):111317. PubMed ID: 36070699
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms Driving mRNA Degradation by m
Lee Y; Choe J; Park OH; Kim YK
Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
[TBL] [Abstract][Full Text] [Related]
16. Targeted m
Rauch S; He C; Dickinson BC
J Am Chem Soc; 2018 Sep; 140(38):11974-11981. PubMed ID: 30183280
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m
Hong L; Pu X; Gan H; Weng L; Zheng Q
J Cancer; 2021; 12(13):3809-3818. PubMed ID: 34093789
[TBL] [Abstract][Full Text] [Related]
19. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
